https://www.has-sante.fr/jcms/p_3334854/fr/opdivo-nivolumab-adenocarcinome-gastrique-de-la-jonction-oeso-gastrique-ou-de-l-oesophage 2022 false false false France French evaluation of the transparency committee adenocarcinoma of esophagus traction Nivolumab Opdivo adenocarcinoma esophagospasm Esophagus esophagogastric junction nivolumab indication of stomach, nos adenocarcinoma of esophagus indicators and reagents Esophagus indicators Esophagus adenocarcinoma junctional